-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Scientists at the University of Birmingham have called for changes in medical policies.
Up to 10% of adults have benign tumors or masses on the adrenal glands, called "adrenal incidental tumors
Now, an international research team conducted by the University of Birmingham in the UK has carried out the largest ever prospective study of more than 1305 patients in the adrenal position to assess the risk of hypertension and type 2 diabetes and their cortisol production, comparing patients with and without mac
Their findings, published in the Annals of Internal Medicine today (January 3), show that MACS is more common than previously reported: MACS is present in almost every 2 patients with adrenal incidental tumors in the study
The first author, Dr.
Professor Wiebke Arlt, director of the Institute of Metabolism and Systems at the University of Birmingham and senior author, said: "Previous studies have shown that MACS is associated with poor health
The research was funded by the British Diabetes Association, the European Commission, the Medical Research Council and the Claire Khan Trust Fund at Birmingham University Hospital
Dr.
Professor Alter added: “Since we have determined that MACS is an important risk factor for hypertension and type 2 diabetes, our research will focus on three main areas
The study took three years to complete and is part of EURINE-ACT
Article title
Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multi-centre study